T. Rowe Price Associates’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.37M | Buy |
|
|||||
|
2025
Q2 | $586K | Buy |
|
|||||
|
2025
Q1 | $205K | Hold |
|
|||||
|
2024
Q4 | $219K | Buy |
|
|||||
|
2024
Q3 | $181K | Hold |
|
|||||
|
2024
Q2 | $106K | Sell |
|
|||||
|
2024
Q1 | $2.76M | Buy |
|
|||||
|
2023
Q4 | $13.2M | Buy |
|
|||||
|
2023
Q3 | $444K | Buy |
|
|||||
|
2023
Q2 | $499K | Buy |
|
|||||
|
2023
Q1 | $661K | Buy |
|
|||||
|
2022
Q4 | $579K | Buy |
|